AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data
Launched by QUN ZHAO · Apr 26, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Histologically confirmed gastric adenocarcinoma
- • Scheduled for curative-intent gastrectomy with lymphadenectomy
- • Completed preoperative imaging with contrast-enhanced CT or MRI
- • Available preoperative biopsy pathology report
- • Able and willing to provide written informed consent
- Exclusion Criteria:
- • Evidence of distant metastasis on preoperative imaging
- • Prior chemotherapy, radiotherapy, or major abdominal surgery
- • Severe comorbidities contraindicating surgery
- • Incomplete or poor-quality preoperative imaging or pathology data
- • Pregnancy or lactation
About Qun Zhao
Qun Zhao is a dedicated clinical trial sponsor with a robust commitment to advancing medical research and improving patient outcomes. With expertise in designing and implementing innovative clinical studies, Qun Zhao focuses on developing new therapies and interventions across various therapeutic areas. The organization prioritizes ethical standards, rigorous scientific methodologies, and collaboration with healthcare professionals and regulatory bodies to ensure the integrity and success of its trials. Through a patient-centered approach, Qun Zhao aims to contribute significantly to the evolving landscape of healthcare and drive transformative solutions for unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shijiazhuang, None Selected, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported